BR0010658A - Formas cristalinas de sal de sódio de 5-cloro-2-metóxi-n-(2-(4metóxi-3-metilaminotiocarbon ilaminossulfonilfenil)etil)benzamida - Google Patents

Formas cristalinas de sal de sódio de 5-cloro-2-metóxi-n-(2-(4metóxi-3-metilaminotiocarbon ilaminossulfonilfenil)etil)benzamida

Info

Publication number
BR0010658A
BR0010658A BR0010658-5A BR0010658A BR0010658A BR 0010658 A BR0010658 A BR 0010658A BR 0010658 A BR0010658 A BR 0010658A BR 0010658 A BR0010658 A BR 0010658A
Authority
BR
Brazil
Prior art keywords
methoxy
benzamide
ethyl
sodium salt
crystalline forms
Prior art date
Application number
BR0010658-5A
Other languages
English (en)
Inventor
Heinrich Christian Englert
Uwe Gerlach
Tobias Metzenthin
Harald Schneider
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of BR0010658A publication Critical patent/BR0010658A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/40—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
    • C07C335/42—Sulfonylthioureas; Sulfonylisothioureas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Patente de Invenção: "FORMAS CRISTALINAS DE SAL DE SóDIO DE 5-CLORO-2-METóXI-N-(2-(4-METóXI-3-METILAMINOTIOCARBO NILAMINOSSULFONILFENIL)ETIL)BENZAMIDA". A presente invenção refere-se a formas cristalinas do sal de sódio de 5-cloro-2-metóxi-N-(2-(4-metóxi-3-metilaminotiocarbonilaminossulfonil fenil)etil)benzamida, processos para sua preparação, seu uso e preparações farmacêuticas compreendendo as mesmas.
BR0010658-5A 1999-04-16 2000-04-04 Formas cristalinas de sal de sódio de 5-cloro-2-metóxi-n-(2-(4metóxi-3-metilaminotiocarbon ilaminossulfonilfenil)etil)benzamida BR0010658A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19917233A DE19917233A1 (de) 1999-04-16 1999-04-16 Kristalline Formen des Natriumsalzes des 5-Chlor-2-methoxy-N-(2-(4-methoxy-3-methylaminothiocarbonylaminosulfonyl-phenyl)-ethyl)- benzamids
PCT/EP2000/002984 WO2000063167A1 (en) 1999-04-16 2000-04-04 Crystalline forms of the sodium salt of 5- chloro -2- methoxy -n- (2- (4-methoxy -3- methyl aminothio carbonylamino sulfonylphenyl) ethyl) benzamide

Publications (1)

Publication Number Publication Date
BR0010658A true BR0010658A (pt) 2002-02-19

Family

ID=7904803

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0010658-5A BR0010658A (pt) 1999-04-16 2000-04-04 Formas cristalinas de sal de sódio de 5-cloro-2-metóxi-n-(2-(4metóxi-3-metilaminotiocarbon ilaminossulfonilfenil)etil)benzamida

Country Status (33)

Country Link
US (1) US6723751B1 (pt)
EP (2) EP1637519B1 (pt)
JP (1) JP4662640B2 (pt)
KR (1) KR100700302B1 (pt)
CN (1) CN1168712C (pt)
AR (1) AR023479A1 (pt)
AT (2) ATE311364T1 (pt)
AU (1) AU773246B2 (pt)
BR (1) BR0010658A (pt)
CA (1) CA2370388C (pt)
CZ (1) CZ302459B6 (pt)
DE (3) DE19917233A1 (pt)
DK (1) DK1173418T3 (pt)
EE (1) EE04612B1 (pt)
ES (1) ES2251996T3 (pt)
HK (1) HK1046270B (pt)
HR (1) HRP20010744B1 (pt)
HU (1) HU229082B1 (pt)
IL (2) IL145921A0 (pt)
ME (1) MEP55708A (pt)
MX (1) MXPA01010275A (pt)
MY (1) MY122588A (pt)
NO (1) NO327798B1 (pt)
NZ (1) NZ514788A (pt)
PL (1) PL203809B1 (pt)
RS (1) RS50916B (pt)
RU (1) RU2235089C2 (pt)
SI (1) SI1173418T1 (pt)
SK (1) SK287175B6 (pt)
TR (2) TR200501142T2 (pt)
TW (1) TWI276622B (pt)
WO (1) WO2000063167A1 (pt)
ZA (1) ZA200108400B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080008440A (ko) * 2003-03-17 2008-01-23 니뽄 다바코 산교 가부시키가이샤 Ｃｅｔｐ 억제제의 약제학적 조성물
TWI494102B (zh) * 2003-05-02 2015-08-01 Japan Tobacco Inc 包含ｓ-〔２（〔〔１-（２-乙基丁基）環己基〕羰基〕胺基）苯基〕２-甲基丙烷硫酯及ｈｍｇ輔酶ａ還原酶抑制劑之組合

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0612724T3 (da) * 1993-02-23 1997-06-16 Hoechst Ag Substituerede benzensulfonylurinstoffer og -thiourinstoffer, fremgangsmåde til deres fremstilling og deres anvendelse som farmaceutika
DE19505397A1 (de) * 1995-02-17 1996-08-22 Hoechst Ag Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
CN1195524C (zh) * 1998-09-10 2005-04-06 阿文蒂斯药物德国有限公司 苯磺酰(硫)脲与β－受体阻滞剂联合在制备用于心脏迷走神经机能障碍治疗和预防的药物中的用途

Also Published As

Publication number Publication date
ATE414059T1 (de) 2008-11-15
EP1637519B1 (en) 2008-11-12
KR100700302B1 (ko) 2007-03-29
NO20015014D0 (no) 2001-10-15
HRP20010744A2 (en) 2003-04-30
CZ20013672A3 (cs) 2002-01-16
NZ514788A (en) 2003-03-28
SK287175B6 (sk) 2010-02-08
CZ302459B6 (cs) 2011-06-01
JP4662640B2 (ja) 2011-03-30
JP2002542230A (ja) 2002-12-10
ZA200108400B (en) 2003-04-30
MEP55708A (en) 2011-05-10
CA2370388C (en) 2009-10-13
MXPA01010275A (es) 2003-07-21
IL145921A (en) 2006-07-05
SI1173418T1 (sl) 2006-02-28
CA2370388A1 (en) 2000-10-26
WO2000063167A1 (en) 2000-10-26
DE19917233A1 (de) 2000-10-19
CN1354744A (zh) 2002-06-19
DK1173418T3 (da) 2006-04-10
EP1637519A1 (en) 2006-03-22
HUP0200791A3 (en) 2005-04-28
HU229082B1 (hu) 2013-07-29
NO327798B1 (no) 2009-09-28
KR20010109355A (ko) 2001-12-08
RU2235089C2 (ru) 2004-08-27
HK1046270A1 (en) 2003-01-03
AU4542800A (en) 2000-11-02
TR200501142T2 (tr) 2005-08-22
ATE311364T1 (de) 2005-12-15
YU72001A (sh) 2004-07-15
EE200100532A (et) 2002-12-16
DE60040811D1 (de) 2008-12-24
EP1173418B1 (en) 2005-11-30
RS50916B (sr) 2010-08-31
ES2251996T3 (es) 2006-05-16
EP1173418A1 (en) 2002-01-23
EE04612B1 (et) 2006-04-17
SK14582001A3 (sk) 2002-01-07
IL145921A0 (en) 2002-07-25
DE60024431T2 (de) 2006-07-27
TWI276622B (en) 2007-03-21
NO20015014L (no) 2001-10-15
DE60024431D1 (en) 2006-01-05
AU773246B2 (en) 2004-05-20
PL351245A1 (en) 2003-04-07
CN1168712C (zh) 2004-09-29
MY122588A (en) 2006-04-29
TR200102993T2 (tr) 2002-03-21
US6723751B1 (en) 2004-04-20
HUP0200791A2 (hu) 2002-07-29
AR023479A1 (es) 2002-09-04
HK1046270B (zh) 2005-03-11
PL203809B1 (pl) 2009-11-30
HRP20010744B1 (en) 2010-08-31

Similar Documents

Publication Publication Date Title
BR0111913A (pt) Análogos de gabapentina para distúrbios do sono
BR0108678A (pt) Novos compostos
BR9713363A (pt) Epotilonas c, d, e e f, preparação e composições
BR0016227A (pt) Derivados de adamantano
BR0111667A (pt) Novos compostos
DK0733046T3 (da) Benzoylguanidiner, deres fremstilling og anvendelse i medikamenter
BR0111319A (pt) Composto, processo para preparar um composto, uso de um composto, processo para preparar um sal de um composto, e, composto intermediário
BR0108893A (pt) Composição farmacêutica, composto e processo de preparação de compostos
PT1193270E (pt) Pirrolobenzodiazepinas
BRPI0411900A (pt) compostos antivirais e métodos
BR9917367A (pt) Método para preparação de citalopram e sua composição farmacêutica
PT688789E (pt) Processo de lipopeptideos processo para a sua preparacao e sua utilizacao
BR9806568A (pt) Forma de cristal de n-(4-trifluormetilfenil)-5-metilisoxazol-4-carboxamida
BR0113590A (pt) 7-oxo-piridopirimidinas
BR0011700A (pt) Dinitrilas de ácido arilmalÈnico substituìdo como intermediários para a preparação de herbicidas
BR0101230A (pt) Processo para a preparação de11-amino-3-cloro-6,11-diidro-5-5-dioxo-6-metil-dibenzo[c,f][1,2]tiazepina e aplicação para a sìntese detianeptina
DE60220055D1 (de) 4-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)harnstoff und dessen verwendung bei der behandlung von mit glycogensynthasekinase-3 (gsk3) assoziierten leiden
ATE253359T1 (de) Antithrombotische mittel
BR0111669A (pt) Novos compostos
DK0634396T3 (da) Aminosyrederivater og deres anvendelse som enkeltfalinaseinhibitorer
BR0113650A (pt) N-(3,5-dicloro-2-metoxifenil)-4-metóxi-3-piperazina-1-il a-benzenossulfonamida
BR0010658A (pt) Formas cristalinas de sal de sódio de 5-cloro-2-metóxi-n-(2-(4metóxi-3-metilaminotiocarbon ilaminossulfonilfenil)etil)benzamida
DE69828522D1 (de) Antithrombotische mittel
BR0016941A (pt) Derivados de aminometil-fenil-ciclohexanona
HUP0102075A2 (hu) Stabil mitoxantron-oldatok, eljárás az előállításukra

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH (DE)

Free format text: ALTERADO DE: AVENTIS PHARMA DEUTSCHLAND GMBH

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL: C07C 335/42, A61K 31/18, A61P 9/06

Ipc: C07C 335/42 (2009.01), A61K 31/18 (2009.01), A61P

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 11, 13 E 24 DA LPI INDEFIRO O PEDIDO DE ACORDO COM O(S)

B12B Appeal against refusal [chapter 12.2 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 16A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.